For: | Spekhorst LM, Oldenburg B, van Bodegraven AA, de Jong DJ, Imhann F, van der Meulen-de Jong AE, Pierik MJ, van der Woude JC, Dijkstra G, D’Haens G, Löwenberg M, Weersma RK, Festen EAM, Parelsnoer Institute and the Dutch Initiative on Crohn and Colitis. Prevalence of- and risk factors for work disability in Dutch patients with inflammatory bowel disease. World J Gastroenterol 2017; 23(46): 8182-8192 [PMID: 29290654 DOI: 10.3748/wjg.v23.i46.8182] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i46/8182.htm |
Number | Citing Articles |
1 |
Pepijn W A Thomas, Nathan den Broeder, Monique Derikx, Wietske Kievit, Rachel L West, Maurice G V M Russel, Jeroen M Jansen, Tessa E H Römkens, Frank Hoentjen. Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective Study. Inflammatory Bowel Diseases 2022; 28(12): 1813 doi: 10.1093/ibd/izac002
|
2 |
Åsa H Everhov, Hamed Khalili, Johan Askling, Pär Myrelid, Jonas F Ludvigsson, Jonas Halfvarson, Caroline Nordenvall, Jonas Söderling, Ola Olén, Martin Neovius. Sick Leave and Disability Pension in Prevalent Patients With Crohn’s Disease. Journal of Crohn's and Colitis 2018; 12(12): 1418 doi: 10.1093/ecco-jcc/jjy123
|
3 |
Alica Kubesch, Patric Boulahrout, Natalie Filmann, Irina Blumenstein, Johannes Hausmann, Giorgos Bamias. Real-world data about emotional stress, disability and need for social care in a German IBD patient cohort. PLOS ONE 2020; 15(1): e0227309 doi: 10.1371/journal.pone.0227309
|
4 |
Kimberley W J van der Sloot, Paul Geertsema, Hanneke C Rijkmans, Michiel D Voskuil, Hendrik M van Dullemen, Marijn C Visschedijk, Eleonora A M Festen, Rinse K Weersma, Behrooz Z Alizadeh, Gerard Dijkstra. Environmental factors associated with biological use and surgery in inflammatory bowel disease. Journal of Gastroenterology and Hepatology 2021; 36(4): 1022 doi: 10.1111/jgh.15223
|
5 |
Sara van Gennep, Nanne K. H. de Boer, Marieke E. Gielen, Svend T. Rietdijk, Krisztina B. Gecse, Cyriel Y. Ponsioen, Marjolijn Duijvestein, Geert R. D’Haens, Mark Löwenberg, Angela G. E. M. de Boer. Impaired Quality of Working Life in Inflammatory Bowel Disease Patients. Digestive Diseases and Sciences 2021; 66(9): 2916 doi: 10.1007/s10620-020-06647-y
|
6 |
Veruscka Leso, Anna Testa, Daniela Pacella, Maria Carmela Macrini, Guido Daniele Villani, Paola Gervetti, Giuseppe Barbato, Antonio Rispo, Fabiana Castiglione, Ivo Iavicoli. The Impact of Inflammatory Bowel Diseases on Patients' Quality of Life and Work Functionality. Journal of Occupational & Environmental Medicine 2024; 66(11): e567 doi: 10.1097/JOM.0000000000003213
|
7 |
Jana Langbrandtner, Gero Steimann, Christoph Reichel, Bernd Bokemeyer, Angelika Hüppe. Berufsbezogene Problemlagen und erwünschte Unterstützungsangebote bei chronisch entzündlichen Darmerkrankungen. Die Rehabilitation 2021; 60(01): 29 doi: 10.1055/a-1248-5703
|
8 |
Sofie Coenen, Marie-Noëlle Schmickler, Daniëlle Staes, Frieda Wieme, Tony Swinnen, Xavier Dekeuleneer, Tineke van Hooland, Kris van den Cruys, Séverine Vermeire. Investing in workability of patients with inflammatory bowel disease: results of a pilot project Activ84worK (Activate for work). European Journal of Gastroenterology & Hepatology 2019; 31(1): 94 doi: 10.1097/MEG.0000000000001257
|
9 |
Sara Nieves Ramos-Cozar, Rafael Martín-Masot, Begoña Rodríguez-Gallego, Leticia Rubio, Juan Luis Cabanillas-Moruno, Víctor Manuel Navas-López. Evaluación de la duración de la baja laboral en pacientes con enfermedad inflamatoria intestinal. Gastroenterología y Hepatología 2024; 47(9): 502194 doi: 10.1016/j.gastrohep.2024.502194
|
10 |
Åsa Everhov, Michael Sachs, Jonas Ludvigsson, Hamed Khalili, Johan Askling, Martin Neovius, Pär Myrelid, Jonas Halfvarson, Caroline Nordenvall, Jonas Söderling, Ola Olen. <p>Work Loss in Relation to Pharmacological and Surgical Treatment for Crohn’s Disease: A Population-Based Cohort Study</p>. Clinical Epidemiology 2020; : 273 doi: 10.2147/CLEP.S244011
|
11 |
Sara Nieves Ramos-Cozar, Rafael Martín-Masot, Begoña Rodríguez-Gallego, Leticia Rubio, Juan Luis Cabanillas-Moruno, Víctor Manuel Navas-López. Assessment of the length of sick leave in patients with inflammatory bowel disease. Gastroenterología y Hepatología (English Edition) 2024; 47(9): 502194 doi: 10.1016/j.gastre.2024.502194
|
12 |
Fenna M Jansen, Stephan R Vavricka, Alfons A den Broeder, Elke MGJ de Jong, Frank Hoentjen, Willemijn A van Dop. Clinical management of the most common extra‐intestinal manifestations in patients with inflammatory bowel disease focused on the joints, skin and eyes. United European Gastroenterology Journal 2020; 8(9): 1031 doi: 10.1177/2050640620958902
|
13 |
Åsa H Everhov, Gustaf Bruze, Jonas Söderling, Johan Askling, Jonas Halfvarson, Karin Westberg, Petter Malmborg, Caroline Nordenvall, Jonas F Ludvigsson, Ola Olén. Women’s Earnings are more Affected by Inflammatory Bowel Disease than Men’s: A Register-Based Swedish Cohort Study. Journal of Crohn's and Colitis 2021; 15(6): 980 doi: 10.1093/ecco-jcc/jjaa238
|
14 |
Sara van Gennep, Marieke E. Gielen, Svend T. Rietdijk, Nanne K.H. de Boer, Marjolijn Duijvestein, Krisztina B. Gecse, Cyriel Y. Ponsioen, Geert R. D’Haens, Angela G.E.M. de Boer, Mark Löwenberg. Work productivity loss is determined by fatigue and reduced quality of life in employed inflammatory bowel disease patients: a prospective multicentre cohort study. European Journal of Gastroenterology & Hepatology 2021; 33(1S): e594 doi: 10.1097/MEG.0000000000002178
|
15 |
Michael Youssef, Nariman Hossein-Javaheri, Tedi Hoxha, Christina Mallouk, Parul Tandon. Work Productivity Impairment in Persons with Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis. Journal of Crohn's and Colitis 2024; 18(9): 1486 doi: 10.1093/ecco-jcc/jjae057
|
16 |
Emma Paulides, Richard B. Gearry, Nanne K.H. de Boer, Chris J.J. Mulder, Charles N. Bernstein, Andrew M. McCombie. Accommodations and Adaptations to Overcome Workplace Disability in Inflammatory Bowel Disease Patients: A Systematic Review. Inflammatory Intestinal Diseases 2018; 3(3): 138 doi: 10.1159/000495293
|
17 |
Srikanth Naramala, Venu Madhav Konala, Sreedhar Adapa, Pravallika Amudala, Romeo C. Castillo, Nikhil Agrawal, Hemant Dhingra. Recurrent Inflammatory Myositis as an Extra-Intestinal Manifestation of Dormant Ulcerative Colitis in a Patient on Long-Term Mesalamine. Case Reports in Gastrointestinal Medicine 2019; 2019: 1 doi: 10.1155/2019/2090379
|
18 |
|
19 |
Benjamin D. Gold, Bridgett Goodwin, Kimberly Davis, Carolyn Sweeney, Maria Reynolds, Jeanne Jiang, Tao Fan, Mena Boules, Szu-Ta Chen, David A. Katzka. Health-Related Quality of Life and Perceived Stigma in Eosinophilic Esophagitis: A Real-World, US, Web-Based Survey. Gastro Hep Advances 2024; 3(8): 1087 doi: 10.1016/j.gastha.2024.07.015
|
20 |
Renata de Sá Brito Fróes, André da Luz Moreira, Antonio José de V. Carneiro, Jessica P. L. Moreira, Ronir R. Luiz, Adriana Maria Hilu de Barros Moreira, Camila Cesar Monnerat, Heitor Siffert Pereira de Souza, Ana Teresa Pugas Carvalho. Prevalence, Indirect Costs, and Risk Factors for Work Disability in Patients with Crohn’s Disease at a Tertiary Care Center in Rio de Janeiro. Digestive Diseases and Sciences 2021; 66(9): 2925 doi: 10.1007/s10620-020-06646-z
|
21 |
Chung Sang Tse, Melissa G Hunt, Lily A Brown, James D Lewis. Inflammatory Bowel Diseases-related Disability: Risk Factors, Outcomes, and Interventions. Inflammatory Bowel Diseases 2024; 30(3): 501 doi: 10.1093/ibd/izad182
|
22 |
Giuseppe Privitera, Daniela Pugliese, Sara Onali, Valentina Petito, Franco Scaldaferri, Antonio Gasbarrini, Silvio Danese, Alessandro Armuzzi. Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy. Autoimmunity Reviews 2021; 20(6): 102832 doi: 10.1016/j.autrev.2021.102832
|
23 |
Mihaela Ionela Sarbu, Nicolae Sarbu. Musculoskeletal clinical and imaging manifestations in inflammatory bowel diseases. Open Medicine 2019; 14(1): 75 doi: 10.1515/med-2019-0011
|